Nature Research Round Table: Parkinson's Disease Therapy with Human Embryonic Stem Cells
Dr. Malin Parmar from Lund University talks about her work on cell-based therapies to treat Parkinson’s disease, as well as regulatory, safety, and efficacy requirements for the clinic. This presentation and the following Q&A session were moderated by Dr. Christine Mummery from the Leiden University Medical Center.
This presentation was part of a Round Table series titled “Challenges in Ensuring hPSC Quality”, hosted in partnership with Nature Research. Global experts gathered at the Springer Nature headquarters in London, UK, to tackle some of the most pertinent issues impacting the use of human pluripotent stem cells (hPSCs), ranging from fundamental biology research to therapeutic applications. Explore the full series here.
Note: Some original data from this presentation has been omitted to abide by copyright rules.
Spotlight on Organoids: Expert Panel
Listen in as organoid experts address topics from RegMedNet's spotlight on organoids. Drs. Meritxell Huch (University of Cambridge), Farzan Pourfarzad (Hubrecht Organoid Technology), Ryan Conder (STEMCELL Technologies), and Sumeer Dhar (AMSBIO) discuss applications, features, and common challenges of organoid cultures.
Studying Cystic Fibrosis Using Primary Human Nasal Epithelial Cells
Cystic Fibrosis (CF) is a genetic disease that affects multiple organs in the body. The primary defects are in the airway and related to epithelial dysfunction. Technological advances have enabled researchers to study CF using specialized in vitro cell culture models to recapitulate the pseudostratified airway epithelium. In this webinar, Dr. Theo Moraes elaborates on the advantages of using nasal epithelial cell cultures to perform such studies and their implications for precision medicine in CF. He also discusses the Program for Individualized Cystic Fibrosis Therapy (CFIT)—a collaboration between CF Canada, SickKids Foundation, and The Hospital for Sick Children—and how it utilizes the nasal culture methodology to develop a nationally accessible resource and to accelerate the development of individualized therapies for CF patients.
Dr. Theo Moraes is a clinician and researcher at The Hospital for Sick Children and the SickKids Research Institute in Toronto, Canada.
EasySep™小鼠TIL（CD45）正选试剂盒
How to Isolate Cells Directly from Whole Blood - EasySep™ Direct Protocol, EasyEights Magnet How to isolate highly purified immune cells from up to 16 whole blood samples at once with EasySep™ Direct on the EasyEights EasySep™ Magnet and the protocol takes as little as 25 minutes from start to finish
Cell Isolation in One Spin Using SepMate™ Tubes and RosetteSep™ Cell Separation Reagents Discover how to easily combine RosetteSep™ cell isolation reagents with the specialized SepMate™ tubes for the rapid isolation of mononuclear cell subsets during density gradient centrifugation
How to Reprogram Fibroblasts into Human Induced Pluripotent Stem (iPS) Cells Using ReproRNA™-OKSGM How to reprogram fibroblasts in using ReproRNA™-OKSGM is a non-integrating, self-replicating RNA reprogramming vector for generating human induced pluripotent stem (iPS) cells
How to Isolate Cells Directly from Whole Blood Using the Easy 50 EasySep™ Magnet: 30-Minute Protocol How to isolate highly purified immune cells directly from whole blood samples of up to 30 mL with and the protocol takes as little as 30 minutes from start to finish
Nature Research Round Table: Parkinson's Disease Therapy with Human Embryonic Stem Cells Dr. Malin Parmar from Lund University talks about her work on cell-based therapies to treat Parkinson’s disease, as well as regulatory, safety, and efficacy requirements for the clinic. This presentation and the following Q&A session were moderated by Dr. Christine Mummery from the Leiden University Medical Center.
Spotlight on Organoids: Expert Panel Listen in as organoid experts address topics from RegMedNet's spotlight on organoids. Drs. Meritxell Huch (University of Cambridge), Farzan Pourfarzad (Hubrecht Organoid Technology), Ryan Conder (STEMCELL Technologies), and Sumeer Dhar (AMSBIO) discuss applications, features, and common challenges of organoid cultures.
How to Grow Cerebral Organoids from Human Pluripotent Stem Cells Guide for growing cerebral organoids, or brain organoids, from human pluripotent stem cells (hPSCs)
Studying Cystic Fibrosis Using Primary Human Nasal Epithelial Cells Cystic Fibrosis (CF) is a genetic disease that affects multiple organs in the body. The primary defects are in the airway and related to epithelial dysfunction. Technological advances have enabled researchers to study CF using specialized in vitro cell culture models to recapitulate the pseudostratified airway epithelium. In this webinar, Dr. Theo Moraes elaborates on the advantages of using nasal epithelial cell cultures to perform such studies and their implications for precision medicine in CF. He also discusses the Program for Individualized Cystic Fibrosis Therapy (CFIT)—a collaboration between CF Canada, SickKids Foundation, and The Hospital for Sick Children—and how it utilizes the nasal culture methodology to develop a nationally accessible resource and to accelerate the development of individualized therapies for CF patients.
EasySep™: Powerful Immunomagnetic Isolation of Virtually Any Cell Type EasySep™ is a powerful immuno-cell separation tech that combines the specificity of mAbs with the simplicity of a column-free system to isolate purified cells
How ALDEFLUOR™ ALDH Assay Kit Detects Normal and Cancer Progenitor Cells How the ALDEFLUOR™ assay works to detect aldehyde dehydrogenase (ALDH)-bright cells
